STOKE THERAPEUTICS ANNOUNCES PRESENTATIONS OF STK-002, AN INVESTIGATIONAL MEDICINE FOR THE TREATMENT OF AUTOSOMAL DOMINANT OPTIC ATROPHY (ADOA), AT THE AMERICAN ACADEMY OF OPHTHALMOLOGY (AAO) 2026 ANNUAL MEETING

Reuters · 4d ago

Please log in to view news